Share This Blog
- Luncheon with the Experts in New York City -- Carcinoid and Neuroendocrine Tumor Patients Are Invited!
- 10 Highlights of the Year 2013 for the Carcinoid and Neuroendocrine Tumor Community
- A Possible Cure for Neuroendocrine Cancer: Exciting Update!
- Carcinoid and Neuroendocrine Tumors and Social Security Disability Benefits
- But You Look So Good . . . Stories by Carcinoid Cancer Survivors
- @a_swisstory sent you an email to connect with others in the #carcinoid #NETCancer community. Hope you got it! 5 days ago
- Do #doctors need guidance treating #NeuroendocrineCancer patients? Great online resource for physicians: bit.ly/1sNdaPg 6 days ago
- Recognizing great #cancer advocates on #FF: @teaminspire, @jangeissler, @myHEARTyrHANDS, @PLANETSCHARITY, @RareDiseases, @DominicNutt. 1 week ago
- @CarcinoidStory, we've learned more about how you connect with/create a group in Switzerland. Can you contact us via our website? 1 week ago
- Dr. Eugene Woltering named Chair of @AJCCancer Expert Panel on #NeuroendocrineTumors. bit.ly/1hXy0Xv http://t.co/aYBuQ52P27 1 week ago
Daily Archives: April 6, 2010
Lexicon Pharmaceuticals’ clinical trial LX1032 for carcinoid syndrome will be among the clinical programs that are reviewed in-depth on April 8, 2010 when the company holds its Annual R&D Day from 7:30 to 11:00 am, Eastern Time, in New York … Continue reading